KATHLEEN G MILLER

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family JEFFERSON, NC NPI 1487022372

General Payments — all program years on this page

$2,887.28

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 181
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $416.18 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $416.1821

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2021 $283.9520
2022 $912.9956
2023 $1,274.1684
2024 $416.1821

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1100648301 Novo Nordisk Inc $15.74 02/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104700515 AstraZeneca Pharmaceuticals LP $15.70 01/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107664988 ABBVIE INC. $22.33 01/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107664990 ABBVIE INC. $14.76 02/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107664992 ABBVIE INC. $13.19 03/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107664994 ABBVIE INC. $13.75 06/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114458541 Exact Sciences Corporation $13.89 02/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132028377 PFIZER INC. $14.49 04/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135713238 Lilly USA, LLC $16.91 02/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135729159 Lilly USA, LLC $15.39 03/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135729161 Lilly USA, LLC $13.55 05/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135734000 Lilly USA, LLC $15.40 03/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137793337 Takeda Pharmaceuticals U.S.A., Inc. $13.69 02/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146767868 IDORSIA PHARMACEUTICALS US INC $16.53 02/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147344440 Mylan Specialty L.P. $13.73 04/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147783432 Supernus Pharmaceuticals, Inc. $25.45 05/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147866558 Supernus Pharmaceuticals, Inc. $87.21 01/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148375666 Axsome Therapeutics, Inc. $15.08 05/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148375668 Axsome Therapeutics, Inc. $25.67 05/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151189402 Phathom Pharmaceuticals, Inc. $15.18 04/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151189404 Phathom Pharmaceuticals, Inc. $18.54 05/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.